Beam Therapeutics (BEAM): The Next Frontier in Biotech
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc
Beam Therapeutics Insider Sold Shares Worth $1,342,752, According to a Recent SEC Filing
Beam Therapeutics Price Target Announced at $24.00/Share by Scotiabank
Beam Therapeutics Initiated With a Sector Perform at Scotiabank
Form 144 | Beam Therapeutics(BEAM.US) Officer Proposes to Sell 4.27 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 7, $Beam Therapeutics(BEAM.US)$ Officer Burrell Terry-Ann intends to sell 185.57K shares of its common stock on Oct 7, with a total market value of approximately $4.27
Bunny R :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
TheOracleOfHindSight : If Harris wins im selling everything & investing in Gold
Tonyco :
Joe P :
tough Platypus_9271 : Harris will say anything to get elected . She has no experience in anything but a prosecutor for California and you see how that went. The emergent.czar , you see how that went too. If she is president, she will not be in charge, she knows nothing about the job, and you really want her to sit down with Putin? This is the worst time to even consider her. Watch the debate tonight at 9 eastern time.
View more comments...